clavis_pharma_nicholas_adams

Clavis Pharma appoints Nicholas Adams

pharmafile | July 13, 2011 | Appointment | Research and Development appointment, research and development 

Norwegian cancer drug development company Clavis Pharma has appointed Nicholas Adams as chief business officer.

He has more than 23 years of experience in the healthcare industry and for the past 12 years worked for UK biotech Antisoma, spending the majority of his time there as vice president business development and a member of the senior management team.

Prior to Antisoma, Nicholas spent eleven years in various positions at Ciba-Geigy (now Novartis), Eisai and Covance.

Advertisement

In his new role at Clavis he replaces Jan Alfheim, who has taken up the position of managing director at Nordic Nanovector AS.

Clavis Pharma’s chief executive Olav Hellebø said: “We are very pleased to welcome Nick to the management team at Clavis Pharma, as he brings to the company his considerable experience in business development particularly in the creation of partnerships with leading pharmaceutical companies, and with a strong focus in oncology.

“This experience will prove to be very important as we increasingly leverage the partnering opportunities for our unique pipeline of novel cancer therapeutics. We also thank Jan for his contribution to Clavis Pharma over the past four years and wish him well in his new role.”

Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months

TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …

The Gateway to Local Adoption Series

Latest content